Name: UMIN ID:
Unique ID issued by UMIN | UMIN000031459 |
---|---|
Receipt number | R000035786 |
Scientific Title | Phase II study of safety and efficacy of alternating R-CHOP and R-HDMA therapy in high-risk diffuse large B-cell lymphoma |
Date of disclosure of the study information | 2018/03/01 |
Last modified on | 2021/04/02 12:57:40 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/02/24 15:23:41 | ||
2 | Update | 2019/03/17 18:29:06 | Recruitment status Date of IRB Last follow-up date |
|
3 | Update | 2019/08/27 13:01:55 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of person sending information Name of person sending information Organization Organization Address Address Tel |
|
4 | Update | 2019/10/16 14:35:52 | UMIN ID1 |
|
5 | Update | 2020/08/27 13:06:49 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
6 | Update | 2020/08/27 13:09:23 | UMIN ID2 |
|
7 | Update | 2021/04/02 12:56:08 | Recruitment status |
|
8 | Update | 2021/04/02 12:57:40 | Number of participants that the trial has enrolled |